IPO

Grand Venture Technology public tranche 15.7 times subscribed; trading starts on Wed
SINGAPORE (Jan 22): Grand Venture Technology (GVT) says its $13.2 million initial public offering (IPO), which closed on Monday at 12 noon, successfully placed out all 42.9 million of its new shares at 27.5 cents. The placement, comprising 0.8 million offer shares and 42.1 million placement shares, was fully subscribed in aggregate at 1.3 times.   Trading of GVT’s shares on the ...
Grand Venture Technology raising $13.2 mil from Catalist IPO
SINGAPORE (Jan 15): Grand Venture Technology (GVT), the homegrown manufacturing solutions and services provider, on Tuesday registered its offer document with the Singapore Exchange for an initial public offer (IPO) on the Catalist board. GVT will be selling 42.9 million new shares at 27.5 cents each, representing 18.3% of the the group’s post-invitation share capital of 234.3 million ...
Singapore IPO funds raised in 2018 falls to second lowest since financial crisis
SINGAPORE (Dec 20): Funds raised through initial public offerings (IPOs) in Singapore have fallen to the second-lowest level in a decade since the global financial crisis in 2008, according to a report by PwC. According to PwC’s Equity Capital Markets Watch – Singapore: 2018 year in review report, the Republic has seen a total of 15 IPOs so far this year, raising approximately $0.73 ...
Biolidics shares slump on Catalist debut
SINGAPORE (Dec 19): Just two hours into its debut on the Singapore Exchange (SGX) Catalist board, shares in medical technology firm Biolidics have slumped 23.2% from its listing price of 28 cents. The stock on Wednesday opened 5.4% lower than its IPO price at 26.5 cents. As at 11.15am, Biolidics is trading at 21.5 cents, with some 4 million shares having changed hands. Login to read: ...
The world's top IPO venue for 2018 sees worst returns in decade
(Dec 19): Hong Kong is host to the world’s busiest venue for initial public offerings this year. And the worst losses in a decade. A boom in technology listings has propelled local deal value to US$35.7 billion ($49.1 billion), ahead of the New York Stock Exchange, according to data compiled by Bloomberg. Yet companies that raised at least US$100 million dropped 6.2% in their first month of ...
Biolidics selling 27.5 mil new shares at 28 cents each in conjunction with Catalist listing
SINGAPORE (Dec 11): Medtech company Biolidics is selling 27.5 million new shares at 28 cents each to retail and institutional investors in a private placement ahead of its listing on the Catalist Board of the Singapore Exchange. See: Clearbridge Health associate Biolidics lodges prelim prospectus Incorporated in 2009, Singapore-based Biolidics is a medical technology company focusing on the ...
Japan's SoftBank prices IPO, to raise $32.2 bil with overallotment
(Dec 10): SoftBank Corp priced its initial public offering (IPO) at 1,500 yen per share and will sell an extra 160 million shares to meet strong demand, a regulatory filing showed, raising 2.65 trillion yen ($32.21 billion) in Japan's biggest-ever IPO. That makes the share sale one of the largest of all time globally, just shy of the record US$25 billion that Chinese e-commerce firm Alibaba ...
Medinex IPO fully subscribed at 25 cents each
SINGAPORE (Dec 5): Medinex, a Singapore-based provider of medical support services, announced that it has successfully completed the placement for its initial public offering (IPO) of 30 million shares, which comprises 26 million new shares and 4 million vendor shares. See: Medinex placing out 30 million shares to raise $7.5 mil ahead of Catalist listing The shares were priced at 25 ...
Medinex placing out 30 million shares to raise $7.5 mil ahead of Catalist listing
SINGAPORE (Dec 1): Medinex, the provider of professional support services to medical clinics, is selling 30 million shares at $0.25 each to raise $7.5 million. This is ahead of its listing on the Catalist board of the Singapore Exchange. Medical support services provider Medinex seeks Catalist listing in all-placement deal Founded in 2009, Medinex helps clients oversee the ...
Clearbridge Health associate Biolidics lodges prelim prospectus
SINGAPORE (Nov 26): Biolidics, a cancer diagnostic solutions developer and an associate company of Clearbridge Health, on Friday lodged a preliminary prospectus for a planned initial public offering (IPO) on the Singapore Exchange's Catalist board. Biolidics, incorporated as Clearbridge Biomedics in 2009, specialises in developing cell enrichment systems that can be combined with other ...